Cencora share price logo

Cencora

NASDAQ: COR

Large Cap

$318.04

+3.35

(+1.06%)

as on

Cencora Stock Performance

as on August 22, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $313.13
    $320.21
    downward going graph

    1.54%

    Downside

    0.68%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $244.82
    $377.54
    downward going graph

    23.02%

    Downside

    18.71%

    Upside

    downward going graph

Cencora share price movements today

Previous Close
$314.69
Open
$314.72
Volume
467.8K
Market Cap
$59.9B
Dividend Yield
0.76%
Day's Low - High
$313.13 - $320.21
52 Week Low - High
$244.82 - $377.54

Cencora Historical Returns

1 Month Return
+ 1.92 %
3 Month Return
+ 21.77 %
1 Year Return
+ 7.17 %
3 Year Return
0 %
5 Year Return
+ 116.31 %

Cencora Stock Fundamentals & Key Indicators

Check Cencora market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$59.9B

EPS (TTM)

13.52

Dividend Yield

0.76%

Quarterly Earnings Growth YOY

0.12%

PE Ratio (TTM)

22.93

Industry PE ratio

17.2725

PEG Ratio

0.601828668083824

EBITDA

5.1B

Revenue (TTM)

332.8B

Profit Margin

3.71%

Return On Equity TTM

106.43%

Cencora Stock Valuation

Track how Cencora P/E has moved over time to understand its valuation trends.

Cencora in the last 5 years

  • Overview

  • Trends

Lowest (15.97x)

September 30, 2021

Industry (17.27x)

September 30, 2025

Today (38.97x)

September 30, 2025

Highest (38.97x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 38.97x

Cencora vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cencora with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$59.9B116.31%22.933.71%0.76%
HOLD$54.7B347.01%31.813.84%0.89%
BUY$101.3B327.83%22.833.64%0.38%
HOLD$10.2B15.89%26.172.96%NA

Stock Returns calculator for Cencora Stock including INR - Dollar returns

The Cencora stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 5Y

  • 7Y

  • 10Y

Cencora investment value today

Current value as on today

₹1,18,657

Returns

₹18,657

(+18.66%)

Returns from Cencora Stock

₹8,613 (+8.61%)

Dollar Impact

₹10,044 (+10.04%)

Analyst Recommendation on Cencora Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.81818181818183% of analysts recommend a 'BUY' rating for Cencora. Average target price of $372.58

Cencora Share Price Target

Get share price movements and forecasts by analysts on Cencora.

What analysts predicted

14.64%UPSIDE

Target Price

$372.58

Current Price

$318.04

Analyzed by

11 Analysts

Target

$372.58

Cencora target price $372.58, a slight upside of 14.64% compared to current price of $318.04. According to 11 analysts rating.

Indian Investors' Interest in Cencora Stock

Search interest for Cencora Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:7% versus previous 30 day period

Cencora Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
68,414
74,241
79,050
81,487
75,453
80,663
83,728
85,932
78,355
84,754
Gross Profit
2,257
2,086
2,163
2,263
2,615
2,658
2,603
2,811
3,322
3,607
Operating Income
868
703
672
791
1,015
985
854
1,016
1,344
1,120
EBITDA
821
966
457
961
1,322
1,269
183
1,041
2,502
1,406
Interest Expense
76
58
54
61
132
116
109
93
154
140
Depreciation
278
278
278
279
261
256
261
260
259
269
Income Before Tax
467
628
125
620
928
896
-187
708
2,088
996
Income Tax Expense
45
140
117
126
211
206
146
142
459
219
Net Income
420
483
3
488
717
687
-339
559
1,641
763
Net Profit Margin
3.30%
2.81%
2.74%
2.78%
3.47%
3.30%
3.11%
3.27%
4.24%
4.26%

Cencora Annual Profit & Loss

All numbers in Millions USD

Sep 2017
Sep 2018
Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Total Revenue
153,143
167,939
179,589
189,893
213,988
238,587
262,173
293,958
321,332
Gross Profit
4,147
4,111
4,530
4,791
6,269
7,600
7,756
8,701
10,141
Operating Income
2,018
1,650
1,866
2,024
2,675
2,751
2,446
3,040
3,647
EBITDA
1,489
1,866
1,651
-4,733
2,909
3,112
3,408
3,364
3,736
Interest Expense
149
189
195
158
182
231
275
248
419
Depreciation
422
499
488
401
505
697
972
1,111
1,058
Income Before Tax
917
1,177
967
-5,293
2,221
2,183
2,160
2,003
2,258
Income Tax Expense
553
-438
112
-1,894
677
516
428
484
690
Net Income
414
1,658
855
-3,399
1,539
1,698
1,745
1,509
1,554
Net Profit Margin
2.71%
2.45%
2.52%
2.52%
2.93%
3.19%
2.96%
2.96%
3.16%

Cencora Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
420
487
88
488
717
689
-339
566
1,641
764
Operating Cash Flow
-878
2,477
1,000
-2,718
3,351
109
3,133
-2,305
1,338
2,654
Investing Cash Flow
-166
-143
-241
-343
-4,077
-234
-321
-299
-4,874
-240
Financing Cash Flow
323
-1,145
-957
3,209
-491
215
-683
43
3,978
-1,767
Change in Cash
-751
1,190
-178
97
-1,216
96
2,080
-2,585
427
628

Cencora Annual Cash Flow

All numbers in Millions USD

Sep 2017
Sep 2018
Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Net Income
414
1,615
854
-3,399
1,544
1,666
1,745
1,519
1,567
Operating Cash Flow
1,489
1,411
2,344
2,207
2,666
2,703
3,911
3,484
3,875
Investing Cash Flow
-498
-1,111
-375
-379
-6,141
-368
-2,602
-618
-4,977
Financing Cash Flow
-1,312
-242
-1,086
-603
1,952
-1,752
-2,222
-2,330
2,249
Change in Cash
-321
57
881
1,223
-1,527
523
-840
544
1,096

Mutual Funds that own Cencora Stock

Check out the Mutual Funds with significant holdings in Cencora.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
9.396829%
17931703
VANGUARD SPECIALIZED FUNDS
1.874348%
3576766
Fidelity Concord Street Trust
1.728405%
3298268
T. ROWE PRICE CAPITAL APPRECIATION FUND, INC.
1.444039%
2755619
T. ROWE PRICE VALUE FUND, INC.
0.748831%
1428973

Global Institutional Holdings in Cencora

Funds
Holdings
Vanguard
11.03%
iShares
6.17%
SPDR
4.23%
Invesco
1.39%
Xtrackers
0.95%

Cencora News & Key Events

  • img

    Today's Timeline - 18 February

    Wed, 06:34 PM

    -

    Cencora to merge MWI Animal Health with Covetrus for $3.5 billion, retaining a 34.3% stake in the combined entity.

Insights on Cencora

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Cencora, Inc. has demonstrated a positive revenue trend over the past two quarters. In the last quarter, revenue increased from $78.35 billion to $84.75 billion, indicating an average growth of 7.6% per quarter.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, COR stock has moved up by 15.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Cardinal Health, Inc. has given 55.0% return, outperforming this stock by 46.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Cencora, Inc. has experienced a decline in its net profit for the last two quarters. The profit decreased from $1.64 billion to $763.51 million, which represents an average decrease of 53.5% each quarter.

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
OrganisationCencora
Headquarters1 West First Avenue, Conshohocken, PA, United States, 19428-1800
IndustryMedical Distribution
CEODr. Robert P. Mauch Ph.D., PharmD
E-voting on sharesClick here to vote

Key Management of Cencora

Name

Title

Ms. Samantha L. Hammock

Executive VP & Chief Human Resources Officer

Dr. Robert P. Mauch Ph.D., PharmD

President, CEO & Director

Ms. Elizabeth S. Campbell J.D.

Executive VP & Chief Legal Officer

Ms. Eva C. Boratto

Executive VP & CFO

Mr. Bennett S. Murphy

Senior VP Of Investor Relations & Enterprise Productivity and Treasury

Mr. Richard Tremonte

EVP and President of U.S. Pharmaceuticals & Animal Health

Mr. James F. Cleary Jr.

Advisor

Ms. Silvana Battaglia

Advisor

Mr. Lazarus Krikorian

Senior VP, Chief Accounting Officer & Corporate Controller

Mr. Pawan Singh Verma

Executive VP and Chief Data & Information Officer

FAQs

What is Cencora share price today?

Cencora share price today is $318.04 as on at the close of the market. Cencora share today touched a day high of $320.21 and a low of $313.13.

What is the 52 week high and 52 week low for Cencora share?

Cencora share touched a 52 week high of $377.54 on and a 52 week low of $244.82 on . Cencora stock price today i.e. is closed at $318.04,which is 15.76% down from its 52 week high and 29.91% up from its 52 week low.

What is Cencora's market capitalisation today?

Cencora market capitalisation is $0.06T as on .

How to invest in Cencora Stock (COR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cencora on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cencora Shares that will get you 0.0047 shares as per Cencora share price of $318.04 per share as on August 22, 2026 at 8:46 am IST.

What is the minimum amount required to buy Cencora Stock (COR) from India?

Indian investors can start investing in Cencora (COR) shares with as little as ₹95.71 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.10 in Cencora stock (as per the Rupee-Dollar exchange rate as on ). Based on Cencora share’s latest price of $318.04 as on August 22, 2026 at 8:46 am IST, you will get 0.0314 shares of Cencora. Learn more about fractional shares .

What are the returns that Cencora has given to Indian investors in the last 5 years?

Cencora stock has given 116.31% share price returns and 29.1% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?